Julier Medical Raises €3 Million in Seed Financing from Sofinnova Partners to Treat Patients with Acute Ischemic Stroke
The funds will support the development of Julier’s thrombectomy solution for faster removal of blood clots and post-stroke revascularization all the way to first-in-humanPARIS, FRANCE / ACCESSWIRE / January 23, 2023 / Julier Medical (“Julier”), a Paris-based medical device company developing an innovative solution for the removal of blood clots and post-stroke revascularization…
Read More
0
